| Technology in Parkinson's disease: challenges and opportunities AJ Espay, P Bonato, FB Nahab, W Maetzler, JM Dean, J Klucken, ... Movement Disorders 31 (9), 1272-1282, 2016 | 656 | 2016 |
| Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease TL Edwards, WK Scott, C Almonte, A Burt, EH Powell, GW Beecham, ... Annals of human genetics 74 (2), 97-109, 2010 | 575 | 2010 |
| The neural processes underlying self-agency FB Nahab, P Kundu, C Gallea, J Kakareka, R Pursley, T Pohida, N Miletta, ... Cerebral cortex 21 (1), 48-55, 2011 | 208 | 2011 |
| Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor D Haubenberger, D Kalowitz, FB Nahab, C Toro, D Ippolito, ... Movement Disorders 26 (11), 2073-2080, 2011 | 128 | 2011 |
| Contagious yawning and the frontal lobe: an fMRI study FB Nahab, N Hattori, ZS Saad, M Hallett Human brain mapping 30 (5), 1744-1751, 2009 | 98 | 2009 |
| Impaired sense of agency in functional movement disorders: an fMRI study FB Nahab, P Kundu, C Maurer, Q Shen, M Hallett PloS one 12 (4), e0172502, 2017 | 87 | 2017 |
| C9ORF72 Intermediate Repeat Copies Are a Significant Risk Factor for Parkinson Disease K Nuytemans, G Bademci, MM Kohli, GW Beecham, L Wang, JI Young, ... Annals of human genetics 77 (5), 351-363, 2013 | 86 | 2013 |
| Dystonia treatment: patterns of medication use in an international cohort S Pirio Richardson, AR Wegele, B Skipper, A Deligtisch, HA Jinnah, ... Neurology 88 (6), 543-550, 2017 | 71 | 2017 |
| Brain networks responsible for sense of agency: an EEG study SY Kang, CH Im, M Shim, FB Nahab, J Park, DW Kim, J Kakareka, ... PloS one 10 (8), e0135261, 2015 | 68 | 2015 |
| Role of the Personal KinetiGraph in the routine clinical assessment of Parkinson’s disease: recommendations from an expert panel R Pahwa, SH Isaacson, D Torres-Russotto, FB Nahab, PM Lynch, ... Expert review of neurotherapeutics 18 (8), 669-680, 2018 | 59 | 2018 |
| Clinical and genetic features of cervical dystonia in a large multicenter cohort MS LeDoux, SR Vemula, J Xiao, MM Thompson, JS Perlmutter, LJ Wright, ... Neurology: Genetics 2 (3), e69, 2016 | 55 | 2016 |
| Clinical and demographic characteristics related to onset site and spread of cervical dystonia SA Norris, HA Jinnah, AJ Espay, C Klein, N Brüggemann, RL Barbano, ... Movement Disorders 31 (12), 1874-1882, 2016 | 53 | 2016 |
| Whole‐Brain Proton MR Spectroscopic Imaging in Parkinson's Disease BE Levin, HL Katzen, A Maudsley, J Post, C Myerson, V Govind, F Nahab, ... Journal of Neuroimaging 24 (1), 39-44, 2014 | 50 | 2014 |
| Essential tremor, deceptively simple… FB Nahab, E Peckham, M Hallett Practical Neurology 7 (4), 222-233, 2007 | 46 | 2007 |
| Octanoic acid in alcohol-responsive essential tremor: a randomized controlled study D Haubenberger, G McCrossin, C Lungu, E Considine, C Toro, FB Nahab, ... Neurology 80 (10), 933-940, 2013 | 43 | 2013 |
| Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine GM Moreno, R Gandhi, SL Lessig, B Wright, I Litvan, FB Nahab Neurology 91 (17), 797-799, 2018 | 41 | 2018 |
| An open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor FB Nahab, L Wittevrongel, D Ippolito, C Toro, GJ Grimes, J Starling, ... Neurotherapeutics 8 (4), 753-762, 2011 | 37 | 2011 |
| Multi-modal hallucinations and cognitive function in Parkinson’s disease H Katzen, C Myerson, S Papapetropoulos, F Nahab, B Gallo, B Levin Dementia and geriatric cognitive disorders 30 (1), 51-56, 2010 | 31 | 2010 |
| Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome FB Nahab, EL Peckham, M Hallett Neurology 71 (12), 950, 2008 | 30 | 2008 |
| Treatment of essential tremor with long-chain alcohols: still experimental or ready for prime time? D Haubenberger, FB Nahab, B Voller, M Hallett Tremor and other hyperkinetic movements 4, 2014 | 23 | 2014 |
